Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway.

Szybowska P, Kostas M, Wesche J, Wiedlocha A, Haugsten EM.

Cells. 2019 May 29;8(6). pii: E518. doi: 10.3390/cells8060518.

2.

Reactivity of platelet-activating and nonplatelet-activating anti-PF4/heparin antibodies in enzyme immunosorbent assays under different conditions.

Nguyen TH, Wesche J, Raschke R, Strobel U, Bui VC, Delcea M, Greinacher A.

J Thromb Haemost. 2019 Apr 22. doi: 10.1111/jth.14455. [Epub ahead of print]

PMID:
31009154
3.

The effect of deloading tape on medial gastrocnemius muscle fascicle behaviour during dynamic exercise.

Obst S, Heales L, Hrelja Z, Ishri P, Wesche J, Barber L.

J Sports Sci. 2019 Apr 2:1-10. doi: 10.1080/02640414.2019.1600225. [Epub ahead of print]

PMID:
30935296
4.

Role of Platelet Size Revisited-Function and Protein Composition of Large and Small Platelets.

Handtke S, Steil L, Palankar R, Conrad J, Cauhan S, Kraus L, Ferrara M, Dhople V, Wesche J, Völker U, Greinacher A, Thiele T.

Thromb Haemost. 2019 Mar;119(3):407-420. doi: 10.1055/s-0039-1677875. Epub 2019 Feb 6.

PMID:
30727004
5.

The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases.

Fafilek B, Balek L, Bosakova MK, Varecha M, Nita A, Gregor T, Gudernova I, Krenova J, Ghosh S, Piskacek M, Jonatova L, Cernohorsky NH, Zieba JT, Kostas M, Haugsten EM, Wesche J, Erneux C, Trantirek L, Krakow D, Krejci P.

Sci Signal. 2018 Sep 18;11(548). pii: eaap8608. doi: 10.1126/scisignal.aap8608.

PMID:
30228226
6.

Proximity Labeling by a Recombinant APEX2-FGF1 Fusion Protein Reveals Interaction of FGF1 with the Proteoglycans CD44 and CSPG4.

Zhen Y, Haugsten EM, Singh SK, Wesche J.

Biochemistry. 2018 Jul 3;57(26):3807-3816. doi: 10.1021/acs.biochem.8b00120. Epub 2018 Jun 13.

PMID:
29812912
7.

Interaction between the Staphylococcus aureus extracellular adherence protein Eap and its subdomains with platelets.

Palankar R, Binsker U, Haracska B, Wesche J, Greinacher A, Hammerschmidt S.

Int J Med Microbiol. 2018 Aug;308(6):683-691. doi: 10.1016/j.ijmm.2018.04.004. Epub 2018 Apr 18.

PMID:
29691140
8.

Secreted Immunomodulatory Proteins of Staphylococcus aureus Activate Platelets and Induce Platelet Aggregation.

Binsker U, Palankar R, Wesche J, Kohler TP, Prucha J, Burchhardt G, Rohde M, Schmidt F, Bröker BM, Mamat U, Pané-Farré J, Graf A, Ebner P, Greinacher A, Hammerschmidt S.

Thromb Haemost. 2018 Apr;118(4):745-757. doi: 10.1055/s-0038-1637735. Epub 2018 Mar 19.

PMID:
29554697
9.

Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors.

Kostas M, Haugsten EM, Zhen Y, Sørensen V, Szybowska P, Fiorito E, Lorenz S, Jones N, de Souza GA, Wiedlocha A, Wesche J.

Mol Cell Proteomics. 2018 May;17(5):850-870. doi: 10.1074/mcp.RA117.000538. Epub 2018 Jan 25.

10.

Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.

Palankar R, Kohler TP, Krauel K, Wesche J, Hammerschmidt S, Greinacher A.

J Thromb Haemost. 2018 Jun;16(6):1187-1197. doi: 10.1111/jth.13955. Epub 2018 Apr 23.

PMID:
29350833
11.

Magnetic Nanoparticle Labeling of Human Platelets from Platelet Concentrates for Recovery and Survival Studies.

Aurich K, Wesche J, Palankar R, Schlüter R, Bakchoul T, Greinacher A.

ACS Appl Mater Interfaces. 2017 Oct 11;9(40):34666-34673. doi: 10.1021/acsami.7b10113. Epub 2017 Sep 29.

PMID:
28945336
12.

Validation of the Vascular quality of life questionnaire - 6 for clinical use in patients with lower limb peripheral arterial disease.

Larsen ASF, Reiersen AT, Jacobsen MB, Kløw NE, Nordanstig J, Morgan M, Wesche J.

Health Qual Life Outcomes. 2017 Sep 22;15(1):184. doi: 10.1186/s12955-017-0760-3.

13.

Editor's Choice - The National Norwegian Carotid Study: Time from Symptom Onset to Surgery is too Long, Resulting in Additional Neurological Events.

Kjørstad KE, Baksaas ST, Bundgaard D, Halbakken E, Hasselgård T, Jonung T, Jørgensen GT, Jørgensen JJ, Krog AH, Krohg-Sørensen K, Laxdal E, Mathisen SR, Oskarsson GV, Seljeskog S, Settemsdal I, Vetrhus M, Viddal BA, Wesche J, Aasgaard F, Mattsson E.

Eur J Vasc Endovasc Surg. 2017 Oct;54(4):415-422. doi: 10.1016/j.ejvs.2017.07.013. Epub 2017 Aug 26.

14.

Protein arginine methylation: a prominent modification and its demethylation.

Wesche J, Kühn S, Kessler BM, Salton M, Wolf A.

Cell Mol Life Sci. 2017 Sep;74(18):3305-3315. doi: 10.1007/s00018-017-2515-z. Epub 2017 Mar 31. Review.

PMID:
28364192
15.

Additional functional outcomes after endovascular treatment for intermittent claudication.

Larsen ASF, Jacobsen MB, Wesche J, Kløw NE.

Acta Radiol. 2017 Aug;58(8):944-951. doi: 10.1177/0284185116679459. Epub 2016 Nov 24.

PMID:
27872352
16.

Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.

Zöllner H, Jouni R, Panzer S, Khadour A, Janzen L, Wesche J, Ten Berg M, Schellong S, Heinken A, Greinacher A, Bakchoul T.

J Thromb Haemost. 2017 Jan;15(1):176-184. doi: 10.1111/jth.13547. Epub 2016 Nov 30.

17.

Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport.

Haugsten EM, Sørensen V, Kunova Bosakova M, de Souza GA, Krejci P, Wiedlocha A, Wesche J.

J Proteome Res. 2016 Oct 7;15(10):3841-3855. Epub 2016 Sep 26.

PMID:
27615514
18.

Assessment of human platelet survival in the NOD/SCID mouse model: technical considerations.

Fuhrmann J, Jouni R, Alex J, Zöllner H, Wesche J, Greinacher A, Bakchoul T.

Transfusion. 2016 Jun;56(6):1370-6. doi: 10.1111/trf.13602. Epub 2016 Apr 18.

PMID:
27086568
19.

Mass spectrometric phosphoproteome analysis of small-sized samples of human neutrophils.

Muschter S, Berthold T, Bhardwaj G, Hammer E, Dhople VM, Wesche J, Reil A, Bux J, Bakchoul T, Steil L, Greinacher A, Völker U.

Clin Chim Acta. 2015 Dec 7;451(Pt B):199-207. doi: 10.1016/j.cca.2015.09.030. Epub 2015 Oct 3.

PMID:
26434552
20.

Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets.

Jouni R, Zöllner H, Khadour A, Wesche J, Grotevendt A, Brandt S, Delcea M, Krauel K, Schwertz H, Sachs UJ, Greinacher A, Bakchoul T.

Thromb Haemost. 2016 Jan;115(2):324-32. doi: 10.1160/TH15-07-0539. Epub 2015 Oct 1.

PMID:
26423467
21.

Flucloxacillin-induced immune thrombocytopenia.

Jatzlauk G, Althaus K, Strobel U, Kiefel V, Wesche J, Muehlenberg K, Greinacher A, Bakchoul T.

Transfusion. 2016 Jan;56(1):67-72. doi: 10.1111/trf.13284. Epub 2015 Sep 1.

PMID:
26331798
22.

HNA antibody-mediated neutrophil aggregation is dependent on serine protease activity.

Berthold T, Schubert N, Muschter S, Rohr M, Wesche J, Reil A, Bux J, Bakchoul T, Greinacher A.

Vox Sang. 2015 Nov;109(4):366-74. doi: 10.1111/vox.12292. Epub 2015 Jun 17.

PMID:
26084778
23.

Impact of priming on the response of neutrophils to human neutrophil alloantigen-3a antibodies.

Berthold T, Muschter S, Schubert N, Wesche J, Ameling S, Teumer A, Reil A, Bux J, Bakchoul T, Greinacher A.

Transfusion. 2015 Jun;55(6 Pt 2):1512-21. doi: 10.1111/trf.12898. Epub 2014 Nov 11.

PMID:
25385443
24.

PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1.

Oppelt A, Haugsten EM, Zech T, Danielsen HE, Sveen A, Lobert VH, Skotheim RI, Wesche J.

Biochem J. 2014 Aug 1;461(3):383-90. doi: 10.1042/BJ20140132.

PMID:
24840251
25.

Photoactivation approaches reveal a role for Rab11 in FGFR4 recycling and signalling.

Haugsten EM, Brech A, Liestøl K, Norman JC, Wesche J.

Traffic. 2014 Jun;15(6):665-83. doi: 10.1111/tra.12168. Epub 2014 Mar 31.

26.

Phosphatidylinositol 5-phosphate is a second messenger important for cell migration.

Haugsten EM, Oppelt A, Wesche J.

Commun Integr Biol. 2013 Sep 1;6(5):e25446. doi: 10.4161/cib.25446. Epub 2013 Jun 28.

27.

RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789.

Nadratowska-Wesolowska B, Haugsten EM, Zakrzewska M, Jakimowicz P, Zhen Y, Pajdzik D, Wesche J, Wiedlocha A.

Oncogene. 2014 Oct 2;33(40):4823-36. doi: 10.1038/onc.2013.425. Epub 2013 Oct 21.

PMID:
24141780
28.

Human neutrophil antigen-3a antibodies induce neutrophil aggregation in a plasma-free medium.

Schubert N, Berthold T, Muschter S, Wesche J, Fürll B, Reil A, Bux J, Bakchoul T, Greinacher A.

Blood Transfus. 2013 Oct;11(4):541-7. doi: 10.2450/2013.0294-12. Epub 2013 Jul 11.

29.

Expression of the CTL2 transcript variants in human peripheral blood cells and human tissues.

Flesch BK, Wesche J, Berthold T, Goldmann T, Hundt M, Greinacher A, Bux J.

Transfusion. 2013 Dec;53(12):3217-23. doi: 10.1111/trf.12160. Epub 2013 Mar 11.

PMID:
23480595
30.

ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling.

Zakrzewska M, Haugsten EM, Nadratowska-Wesolowska B, Oppelt A, Hausott B, Jin Y, Otlewski J, Wesche J, Wiedlocha A.

Sci Signal. 2013 Feb 12;6(262):ra11. doi: 10.1126/scisignal.2003087.

PMID:
23405013
31.

Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration.

Oppelt A, Lobert VH, Haglund K, Mackey AM, Rameh LE, Liestøl K, Schink KO, Pedersen NM, Wenzel EM, Haugsten EM, Brech A, Rusten TE, Stenmark H, Wesche J.

EMBO Rep. 2013 Jan;14(1):57-64. doi: 10.1038/embor.2012.183. Epub 2012 Nov 16.

32.

Does venous insufficiency impair the exercise-induced rise in arterial leg blood flow?

Nådland IH, Wesche J, Sheriff DD, Toska K.

Phlebology. 2011 Dec;26(8):326-31. doi: 10.1258/phleb.2011.010092. Epub 2011 Sep 21.

PMID:
21937517
33.

Clathrin- and dynamin-independent endocytosis of FGFR3--implications for signalling.

Haugsten EM, Zakrzewska M, Brech A, Pust S, Olsnes S, Sandvig K, Wesche J.

PLoS One. 2011;6(7):e21708. doi: 10.1371/journal.pone.0021708. Epub 2011 Jul 14.

34.

Epitope mapping of antibodies directed against the human neutrophil alloantigen 3a.

Berthold T, Wesche J, Kuhnert K, Fürll B, Hippe H, Hoppen J, Reil A, Muschter S, Bux J, Greinacher A.

Transfusion. 2011 Oct;51(10):2160-7. doi: 10.1111/j.1537-2995.2011.03115.x. Epub 2011 Mar 24.

PMID:
21756260
35.

Fibroblast growth factors and their receptors in cancer.

Wesche J, Haglund K, Haugsten EM.

Biochem J. 2011 Jul 15;437(2):199-213. doi: 10.1042/BJ20101603. Review.

PMID:
21711248
36.

Does the great saphenous vein stripping improve arterial leg blood flow during exercise?

Nådland IH, Wesche J, Sheriff DD, Toska K.

Eur J Vasc Endovasc Surg. 2011 May;41(5):697-703. doi: 10.1016/j.ejvs.2011.01.022. Epub 2011 Mar 3.

37.

Roles of fibroblast growth factor receptors in carcinogenesis.

Haugsten EM, Wiedlocha A, Olsnes S, Wesche J.

Mol Cancer Res. 2010 Nov;8(11):1439-52. doi: 10.1158/1541-7786.MCR-10-0168. Epub 2010 Oct 13. Review.

38.

Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes.

Lobert VH, Brech A, Pedersen NM, Wesche J, Oppelt A, Malerød L, Stenmark H.

Dev Cell. 2010 Jul 20;19(1):148-59. doi: 10.1016/j.devcel.2010.06.010.

39.

Geno- and phenotyping and immunogenicity of HNA-3.

Reil A, Wesche J, Greinacher A, Bux J.

Transfusion. 2011 Jan;51(1):18-24. doi: 10.1111/j.1537-2995.2010.02751.x.

PMID:
20561293
40.

Cindr interacts with anillin to control cytokinesis in Drosophila melanogaster.

Haglund K, Nezis IP, Lemus D, Grabbe C, Wesche J, Liestøl K, Dikic I, Palmer R, Stenmark H.

Curr Biol. 2010 May 25;20(10):944-50. doi: 10.1016/j.cub.2010.03.068. Epub 2010 May 6.

41.

Characterization of the human neutrophil alloantigen-3a.

Greinacher A, Wesche J, Hammer E, Fürll B, Völker U, Reil A, Bux J.

Nat Med. 2010 Jan;16(1):45-8. doi: 10.1038/nm.2070. Epub 2009 Dec 27.

PMID:
20037594
42.

[Epidemiology, investigation and treatment indication in aortic aneurysm].

Wesche J.

Tidsskr Nor Laegeforen. 2009 Oct 22;129(20):2124-6. doi: 10.4045/tidsskr.09.0160. Review. Norwegian. No abstract available.

43.

Size limitation in translocation of fibroblast growth factor 1 fusion proteins across the endosomal membrane.

Zakrzewska M, Zhen Y, Wiedlocha A, Olsnes S, Wesche J.

Biochemistry. 2009 Aug 4;48(30):7209-18. doi: 10.1021/bi9007353.

PMID:
19558187
44.

Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis.

Haugsten EM, Malecki J, Bjørklund SM, Olsnes S, Wesche J.

Mol Biol Cell. 2008 Aug;19(8):3390-403. doi: 10.1091/mbc.E07-12-1219. Epub 2008 May 14.

45.

A nuclear export sequence located on a beta-strand in fibroblast growth factor-1.

Nilsen T, Rosendal KR, Sørensen V, Wesche J, Olsnes S, Wiedłocha A.

J Biol Chem. 2007 Sep 7;282(36):26245-56. Epub 2007 Jul 6.

46.

Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.

Sørensen V, Wiedlocha A, Haugsten EM, Khnykin D, Wesche J, Olsnes S.

J Cell Sci. 2006 Oct 15;119(Pt 20):4332-41. Epub 2006 Sep 26.

47.

Flat clathrin coats on endosomes mediate degradative protein sorting by scaffolding Hrs in dynamic microdomains.

Raiborg C, Wesche J, Malerød L, Stenmark H.

J Cell Sci. 2006 Jun 15;119(Pt 12):2414-24. Epub 2006 May 23.

48.

FGF-1 and FGF-2 require the cytosolic chaperone Hsp90 for translocation into the cytosol and the cell nucleus.

Wesche J, Małecki J, Wiedłocha A, Skjerpen CS, Claus P, Olsnes S.

J Biol Chem. 2006 Apr 21;281(16):11405-12. Epub 2006 Feb 22.

49.

Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors.

Haugsten EM, Sørensen V, Brech A, Olsnes S, Wesche J.

J Cell Sci. 2005 Sep 1;118(Pt 17):3869-81. Epub 2005 Aug 9.

50.

Encapsulation of islets in rough surface, hydroxymethylated polysulfone capillaries stimulates VEGF release and promotes vascularization after transplantation.

Lembert N, Wesche J, Petersen P, Doser M, Zschocke P, Becker HD, Ammon HP.

Cell Transplant. 2005;14(2-3):97-108.

PMID:
15881419

Supplemental Content

Loading ...
Support Center